Summit Trail Advisors, LLC Astrazeneca PLC Transaction History

Summit Trail Advisors, LLC

$3.97 Billion
Q3 2024

A detailed history of Summit Trail Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 7,675 shares of AZN stock, worth $511,154. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,675

Previous 8,597 10.72%

Holding current value

$511,154

Previous $670,000 10.75%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $70,689 - $80,785	-922 Reduced 10.72%	7,675 $598,000
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $144,242 - $174,511	2,159 Added 33.54%	8,597 $670,000
Q1 2024 Apr 23, 2024	SELL	$61.03 - $69.57 $36,618 - $41,741	-600 Reduced 8.53%	6,438 $436,000
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $16,895 - $18,913	273 Added 4.04%	7,038 $474,000
Q3 2023 Oct 30, 2023	SELL	$64.85 - $71.7 $211,864 - $234,243	-3,267 Reduced 32.57%	6,765 $458,000
Q2 2023 Jul 25, 2023	BUY	$69.91 - $75.81 $344,726 - $373,819	4,931 Added 96.67%	10,032 $717,000
Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $322,128 - $365,231	5,101 New	5,101 $354,000
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $213,691 - $256,530	-3,606 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $50,816 - $61,213	-912 Reduced 20.19%	3,606 $239,000
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $49,698 - $58,723	920 Added 25.57%	4,518 $263,000
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $199,904 - $218,722	3,598 New	3,598 $216,000
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $173,168 - $194,920	-4,698 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $163,302 - $186,604	4,698 New	4,698 $186,000
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $611,224 - $655,451	-17,691 Closed	0 $0
Q1 2018 May 22, 2018	SELL	$32.97 - $36.63 $9.37 Million - $10.4 Million	-284,302 Reduced 94.14%	17,691 $302,000
Q1 2018 May 21, 2018	BUY	$32.97 - $36.63 $9.42 Million - $10.5 Million	285,673 Added 1750.45%	301,993 $302,000
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $523,708 - $567,609	16,320	16,320 $578,000

Others Institutions Holding AZN

# of Institutions

1,349

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Account

Summit Trail Advisors, LLC Astrazeneca PLC Transaction History